Caldwell J D, Jirikowski G F
Lake Erie College of Osteopathic Medicine, Erie, PA 16509, USA.
Horm Metab Res. 2009 Mar;41(3):173-82. doi: 10.1055/s-0028-1093351. Epub 2008 Oct 27.
New and more active concepts of steroid binding globulin action are emerging from recent research. As a result, examination of steroid levels in aging humans and the role of steroid binding globulins need to be re-visited. This review will discuss the possibility that sex hormone binding globulin (SHBG) plays an active role in the aging process. It will discuss the changes in blood levels of SHBG in aging humans in association with sexual activity, prostate hypertrophy and cancer, uterine leiomyoma, breast cancer, obesity and particularly the relationship between SHBG and HDL-cholesterol, Alzheimer's disease, osteoporosis, and cardiovascular disease. Starting with the idea that SHBG is an active participant in steroid action demands a re-evaluation of data demonstrating a primary change in blood SHBG levels in association with various pathologies. Here we discuss the postulate that SHBG may act at its own receptor at the plasma membrane level to influence other receptors such as scavenger receptors and HDL-cholesterol receptors. We will also suggest that SHBG is a critical marker for mating and thus may be an important physiological molecule in control of aging.
近期研究中出现了关于类固醇结合球蛋白作用的更新且更具活性的概念。因此,有必要重新审视老年人体内类固醇水平以及类固醇结合球蛋白的作用。本综述将探讨性激素结合球蛋白(SHBG)在衰老过程中发挥积极作用的可能性。它将讨论老年人体内SHBG血液水平的变化与性活动、前列腺肥大和癌症、子宫肌瘤、乳腺癌、肥胖的关系,特别是SHBG与高密度脂蛋白胆固醇、阿尔茨海默病、骨质疏松症和心血管疾病之间的关系。从SHBG是类固醇作用的积极参与者这一观点出发,需要重新评估那些表明血液SHBG水平与各种病理状况存在主要变化的数据。在此,我们讨论这样一种假设,即SHBG可能在质膜水平作用于其自身受体,以影响其他受体,如清道夫受体和高密度脂蛋白胆固醇受体。我们还将提出,SHBG是交配的关键标志物,因此可能是控制衰老的重要生理分子。